Shareholder plans Gentex (NASDAQ: GNTX) sale of 11,248 shares

Rhea-AI Filing Summary

A shareholder of Gentex Corporation filed a notice of proposed sale under Rule 144 to sell 11,248 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of 02/17/2026 and an aggregate market value of $279,175.36.

The notice shows that these shares were acquired on 02/16/2026 via 2,332 restricted stock units vesting under a registered plan and 8,916 performance stock units, both paid for in cash. Gentex had 218,942,919 shares outstanding at the time, providing context for the size of the planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11248	279175.36	218942919	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2026	Restricted stock vesting under a registered plan	Issuer			2332	02/16/2026	Cash
Common	02/16/2026	Performance Stock Units	Issuer			8916	02/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for GNTX disclose?

The filing discloses a planned sale of Gentex shares under Rule 144. A shareholder intends to sell 11,248 common shares on NASDAQ, with an aggregate market value of $279,175.36, after acquiring them through recent restricted stock and performance unit vesting.

How many Gentex (GNTX) shares are planned to be sold under this Form 144?

The Form 144 covers a proposed sale of 11,248 Gentex common shares. These shares are to be sold through Morgan Stanley Smith Barney’s Executive Financial Services on NASDAQ, giving an aggregate market value of $279,175.36 based on the figures in the notice.

When were the Gentex (GNTX) shares in this Form 144 acquired?

The shares were acquired on 02/16/2026. The filing shows 2,332 shares from restricted stock vesting under a registered plan and 8,916 shares from performance stock units, with both transactions paid in cash on the same date.

What is the approximate sale date in the Gentex (GNTX) Form 144?

The approximate sale date listed is 02/17/2026. The Form 144 indicates that the 11,248 Gentex common shares are expected to be sold around this date on the NASDAQ exchange through Morgan Stanley Smith Barney’s Executive Financial Services unit.

How large is the planned Gentex (GNTX) share sale relative to shares outstanding?

The planned sale is small versus total Gentex shares outstanding. The notice lists 11,248 common shares to be sold, while Gentex had 218,942,919 shares outstanding, providing context for the relative size of this Rule 144 transaction.

How were the Gentex (GNTX) shares in the Form 144 paid for?

The filing states the shares were paid for in cash. Both the restricted stock vesting and the performance stock units, totaling 11,248 shares acquired on 02/16/2026, list cash as the nature of payment in the Form 144 disclosure.